The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of cancer treatment response from histopathology images through imputed transcriptomics.
 
Danh-Tai Hoang
No Relationships to Disclose
 
Gal Dinstag
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Leandro C. Hermida
No Relationships to Disclose
 
Doreen Ben-Zvi
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Chani Stossel
No Relationships to Disclose
 
Tejas Patil
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; Elevation Oncology; Janssen; Mirati Therapeutics; Pfizer; Regeneron; Sanofi; Takeda; Turning Point Therapeutics
Research Funding - EMD Serono; Janssen
(OPTIONAL) Uncompensated Relationships - Guardant Health
 
Stephen-John Sammut
No Relationships to Disclose
 
Wiem Lassoued
No Relationships to Disclose
 
Clint Allen
No Relationships to Disclose
 
Tuvik Beker
Employment - Pangaea Biotech
Leadership - MedAware; Pangaea Biotech
Stock and Other Ownership Interests - MedAware; Pangaea Biotech
Patents, Royalties, Other Intellectual Property - Patents and pending patents assigned to MedAware and Pangea
 
Peng Jiang
No Relationships to Disclose
 
Talia Golan
Honoraria - Abbvie; AstraZeneca/MedImmune; MSD
Consulting or Advisory Role - Abbvie; AstraZeneca
Speakers' Bureau - AstraZeneca; MSD Oncology
Research Funding - AstraZeneca (Inst); MSD (Inst)
 
Adam G. Sowalsky
No Relationships to Disclose
 
Sharon R Pine
No Relationships to Disclose
 
Carlos Caldas
Consulting or Advisory Role - AstraZeneca/MedImmune; Illumina
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); SERVIER (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Marengo Therapeutics (Inst); Merck (Inst); NextCure (Inst); PDS Biotechnology (Inst); Pfizer (Inst); Precigen (Inst); Syndax (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Publication number: 20200062849 Abstract: The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subje
 
Kenneth D. Aldape
No Relationships to Disclose
 
Ranit Aharonov
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Eric Stone
No Relationships to Disclose
 
Eytan Ruppin
Stock and Other Ownership Interests - MedAware; Metabomed
Consulting or Advisory Role - Pangaea Biotech
Patents, Royalties, Other Intellectual Property - Patent applications have been submitted by Te-Aviv University, U Maryland and NCI for synthetic lethality and expression deconvolution computational analysis approaches
(OPTIONAL) Uncompensated Relationships - Pangea